Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3.61%1.84B | 1.13%899.48M | 4.06%1.78B | 3.85%889.46M | 0.43%1.71B | 4.30%856.52M | -9.13%1.7B | -11.86%821.18M | 6.92%1.87B | 11.04%931.7M |
| Operating income | 3.61%1.84B | 1.13%899.48M | 4.06%1.78B | 3.85%889.46M | 0.43%1.71B | 4.30%856.52M | -9.13%1.7B | -11.86%821.18M | 6.92%1.87B | 11.04%931.7M |
| Cost of sales | -3.34%-1.46B | -0.44%-704.93M | -3.91%-1.41B | -4.62%-701.84M | -1.04%-1.36B | -7.19%-670.86M | 6.65%-1.35B | 9.13%-625.85M | -9.93%-1.44B | -13.78%-688.76M |
| Operating expenses | -3.34%-1.46B | -0.44%-704.93M | -3.91%-1.41B | -4.62%-701.84M | -1.04%-1.36B | -7.19%-670.86M | 6.65%-1.35B | 9.13%-625.85M | -9.93%-1.44B | -13.78%-688.76M |
| Gross profit | 4.64%383.85M | 3.70%194.56M | 4.64%366.81M | 1.05%187.62M | -1.90%350.56M | -4.95%185.66M | -17.42%357.36M | -19.60%195.34M | -2.02%432.74M | 3.94%242.94M |
| Selling expenses | 57.77%-3.08M | -981.87%-1.97M | -12.48%-7.3M | -45.60%-182K | -29.40%-6.49M | 93.11%-125K | 59.44%-5.01M | 76.17%-1.81M | 1.74%-12.36M | -19.34%-7.61M |
| Administrative expenses | 2.93%-200.4M | 9.81%-87.16M | -7.33%-206.45M | -2.67%-96.64M | 8.47%-192.35M | -0.28%-94.13M | 7.56%-210.14M | 18.21%-93.87M | 4.65%-227.32M | -13.37%-114.77M |
| Impairment and provision | 27.52%-29.78M | -25.70%-29.48M | 29.95%-41.09M | 10.41%-23.45M | -8.43%-58.66M | -20.61%-26.18M | -67.46%-54.1M | -12.70%-21.7M | -41.47%-32.31M | 48.95%-19.26M |
| -Other impairment is provision | 27.52%-29.78M | -25.70%-29.48M | 29.95%-41.09M | 10.41%-23.45M | -8.43%-58.66M | -20.61%-26.18M | -67.46%-54.1M | -12.70%-21.7M | -41.47%-32.31M | 48.95%-19.26M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.45M | 64.69%-6.38M | ---- |
| Special items of operating profit | -96.32%960K | 13.46%12.27M | -18.42%26.12M | -15.92%10.81M | -25.39%32.02M | -20.17%12.86M | 32.10%42.92M | -19.30%16.11M | -35.09%32.49M | -25.71%19.96M |
| Operating profit | 9.74%151.54M | 12.88%88.22M | 10.40%138.1M | 0.09%78.16M | -4.53%125.08M | -15.68%78.09M | -29.88%131.02M | -23.64%92.61M | -6.48%186.87M | 5.20%121.27M |
| Financing cost | 13.56%-2.05M | 0.69%-865K | 29.95%-2.37M | 8.41%-871K | -17.20%-3.38M | ---951K | ---2.88M | ---- | ---- | 42.81%-5.06M |
| Share of profits of associates | 33.86%506K | -147.15%-1.34M | 126.35%378K | 317.14%2.84M | -87.24%167K | -470.25%-1.31M | 9.63%1.31M | -31.98%353K | 465.88%1.19M | 41.80%519K |
| Share of profit from joint venture company | -73.62%626K | -260.92%-906K | -16.38%2.37M | -80.58%563K | -10.39%2.84M | 8.94%2.9M | 12.15%3.17M | 9.42%2.66M | 8.82%2.82M | 36.17%2.43M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -872.67%-4.48M |
| Earning before tax | 8.77%150.63M | 5.49%85.11M | 11.04%138.48M | 2.49%80.69M | -5.96%124.71M | -17.67%78.73M | -30.53%132.61M | -16.62%95.62M | -5.79%190.88M | 6.06%114.68M |
| Tax | 18.53%-37.76M | -8.06%-26.22M | -13.79%-46.35M | 3.40%-24.27M | 6.49%-40.74M | 14.09%-25.12M | 25.97%-43.56M | 8.19%-29.24M | -13.51%-58.84M | 3.53%-31.84M |
| After-tax profit from continuing operations | 22.51%112.86M | 4.38%58.89M | 9.71%92.13M | 5.25%56.42M | -5.70%83.97M | -19.24%53.61M | -32.56%89.05M | -19.86%66.38M | -12.43%132.04M | 10.28%82.83M |
| Earning after tax | 22.51%112.86M | 4.38%58.89M | 9.71%92.13M | 5.25%56.42M | -5.70%83.97M | -19.24%53.61M | -32.56%89.05M | -19.86%66.38M | -12.43%132.04M | 10.28%82.83M |
| Minority profit | 354.40%14.68M | 6.27%5.97M | -17.56%3.23M | 10.75%5.61M | -67.73%3.92M | -8.85%5.07M | -52.86%12.14M | -59.86%5.56M | 33.66%25.76M | 11.04%13.85M |
| Profit attributable to shareholders | 10.45%98.19M | 4.17%52.93M | 11.05%88.9M | 4.67%50.81M | 4.09%80.05M | -20.19%48.54M | -27.64%76.91M | -11.82%60.82M | -19.18%106.28M | 10.13%68.98M |
| Basic earnings per share | 10.58%0.115 | 5.08%0.062 | 10.64%0.104 | 3.51%0.059 | 4.44%0.094 | -19.72%0.057 | -27.42%0.09 | -12.35%0.071 | -21.02%0.124 | 6.58%0.081 |
| Diluted earnings per share | 10.58%0.115 | 5.08%0.062 | 10.64%0.104 | 3.51%0.059 | 4.44%0.094 | -19.72%0.057 | -27.42%0.09 | -12.35%0.071 | -21.02%0.124 | 6.58%0.081 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.